Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination
Jan 29, 2026, 12:56 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Recalls often lead to immediate declines in stock prices due to investor concerns around safety and revenue impact. Historical instances show a pattern of negative market reactions following product recalls in the health-related sectors.
AI summary
What happened, with direct paths to the underlying reporting
Neogen Corporation has initiated a nationwide recall of all unexpired lots of its Neogen Vet HYCOAT product due to identified microbial contamination. This significant move could negatively affect the company’s sales and reputation in the veterinary market, posing a near-term risk to its stock performance.
NEOG recalls all unexpired lots of HYCOAT due to microbial contamination.
The recall could impact NEOG's sales and reputation significantly.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Neogen reported a solid Q1 2027 with adjusted EPS of $0.08 on $222.8 million in sales, beating forecasts. The company lifted FY2027 revenue guidance to $885-890 million and EBITDA…
The FDA warned Neogen Corp's HYCOAT contamination tied to widespread equine fatalities, the largest such incident in FDA-regulated veterinary products. Regulators cited viable fun…
NEOG is slated to report Q1 after the Oct 6 close, with consensus EPS of $0.05 on about $208.2M in revenue. The stock benefited from better-than-expected Q4 results and multiple a…
Neogen Corporation is set to release its Q3 earnings on April 9, with analysts expecting a drop in earnings per share to 5 cents, down from 10 cents last year. The anticipated rev…